[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2024 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ- 203.47%
YoY- 389.45%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 3,777,382 3,606,430 3,859,836 3,404,481 3,486,232 3,458,376 3,521,816 4.76%
PBT 241,150 84,756 156,176 -62,823 -54,298 31,070 36,772 249.16%
Tax -66,025 -24,706 -51,460 -13,213 -4,310 -20,890 -25,708 87.21%
NP 175,125 60,050 104,716 -76,036 -58,609 10,180 11,064 527.24%
-
NP to SH 172,633 56,886 102,584 -77,452 -59,641 9,216 10,592 539.57%
-
Tax Rate 27.38% 29.15% 32.95% - - 67.24% 69.91% -
Total Cost 3,602,257 3,546,380 3,755,120 3,480,517 3,544,841 3,448,196 3,510,752 1.72%
-
Net Worth -175,036 -272,968 -272,392 -281,734 -245,740 -137,571 -142,812 14.48%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div - - - - - - - -
Div Payout % - - - - - - - -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth -175,036 -272,968 -272,392 -281,734 -245,740 -137,571 -142,812 14.48%
NOSH 1,441,815 1,441,229 1,441,229 1,441,229 1,441,229 1,310,208 1,310,208 6.57%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 4.64% 1.67% 2.71% -2.23% -1.68% 0.29% 0.31% -
ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 261.99 250.23 267.82 248.93 259.62 263.96 268.80 -1.69%
EPS 11.97 3.94 7.12 -5.66 -4.44 0.70 0.80 504.22%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS -0.1214 -0.1894 -0.189 -0.206 -0.183 -0.105 -0.109 7.42%
Adjusted Per Share Value based on latest NOSH - 1,441,255
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 262.09 250.23 267.81 236.22 241.89 239.96 244.36 4.76%
EPS 11.98 3.95 7.12 -5.37 -4.14 0.64 0.73 542.50%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS -0.1214 -0.1894 -0.189 -0.1955 -0.1705 -0.0955 -0.0991 14.44%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 0.39 0.37 0.355 0.385 0.435 0.37 0.285 -
P/RPS 0.15 0.15 0.13 0.15 0.17 0.14 0.11 22.90%
P/EPS 3.26 9.37 4.99 -6.80 -9.79 52.60 35.25 -79.46%
EY 30.70 10.67 20.05 -14.71 -10.21 1.90 2.84 386.77%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 26/11/24 21/08/24 27/05/24 29/02/24 29/11/23 11/08/23 18/05/23 -
Price 0.355 0.43 0.39 0.37 0.405 0.42 0.38 -
P/RPS 0.14 0.17 0.15 0.15 0.16 0.16 0.14 0.00%
P/EPS 2.96 10.89 5.48 -6.53 -9.12 59.71 47.01 -84.09%
EY 33.73 9.18 18.25 -15.31 -10.97 1.67 2.13 527.44%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment